Zobrazeno 1 - 4
of 4
pro vyhledávání: '"second ivig course"'
Autor:
Verboon, C., Van Den Berg, B., Cornblath, D. R., Venema, E., Gorson, K. C., Lunn, M. P., Briani, C., Lingsma, H., Van Den Bergh, P., Harbo, T., Bateman, K., Pereon, Y., Sindrup, So. H., Kusunoki, S., Miller, J., Islam, Z., Hartung, H. -P., Chavada, G., Jacobs, B. C., Hughes, R. A. C., Van Doorn, P. A.
Publikováno v:
Journal of neurology, neurosurgery, and psychiatry, Vol. 91, no. 2, p. 113-121 (2020)
OBJECTIVE: To compare disease course in patients with Guillain-Barré syndrome (GBS) with a poor prognosis who were treated with one or with two intravenous immunoglobulin (IVIg) courses. METHODS: From the International GBS Outcome Study, we selected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::455bfec15d2d0fba25345be235dac79c
https://hdl.handle.net/2078.1/221308
https://hdl.handle.net/2078.1/221308
Autor:
Verboon, C, van den Berg, B, Cornblath, Dr, Venema, E, Gorson, Kc, Lunn, Mp, Lingsma, H, Van den Bergh, P, Harbo, T, Bateman, K, Pereon, Y, Sindrup, Sh, Kusunoki, S, Miller, J, Islam, Z, Hartung, Hp, Chavada, G, Jacobs, Bc, Hughes, Rac, van Doorn PA, Ajroud-Driss S, IGOS Consortium., Antonini, G, Attarian, S, Barroso, Fa, Benedetti, L, Bertorini, Te, Brannagan, Th, Briani, C, Bhavaraju-Sanka, R, Butterworth, S, Casasnovas, C, Cavaletti, G, Chen, S, Claeys, Kg, Cosgrove, Js, Davidson, A, Dardiotis, E, Dornonville de la Cour, C, Faber, Cg, Feasby, Te, Fujioka, T, Galassi, G, Gilchrist, Jm, Goyal, Na, Granit, V, Gutiérrez-Gutiérrez, G, Hadden, Rdm, Holt, Jkl, Htut, M, Jericó Pascual, I, Karafiath, S, Katzberg, Hd, Kiers, L, Kieseier, Bc, Kimpinski, K, Kuwabara, S, Kwan, Jy, Ladha, Ss, Lawson, V, Lehmann, H, Manji, H, Marfia, Ga, Márquez Infante, C, Mattiazzi, Mg, Mcdermott, Cj, Monges, Ms, Morís de la Tassa, G, Nascimbene, C, Nobile Orazio, E, Nowak, Rj, Osei-Bonsu, M, Pardo Fernandez, J, Querol Gutierrez, L, Reisin, R, Rinaldi, S, Rojas-Marcos, I, Rudnicki, Sa, Schenone, A, Sedano Tous MJ, Shahrizaila, N, Sheikh, K, Silvestri, Nj, Sommer, Cl, Varrato, Jd, Verschuuren, J, Vytopil, Mv, Zhou, L, Bella, Ir, Bunschoten, C, Bürmann, J, Busby, M, Chao, Cc, Conti, Me, Dalakas, Mc, Van Damme, P, Doets, A, van Dijk GW, Dimachkie, Mm, Doppler, K, Echaniz-Laguna, A, Eftimov, F, Fazio, R, Fokke, C, Fulgenzi, Ea, Garssen, Mpj, Gijsbers, Cj, Gilhuis, J, Grapperon, A, Hsieh, St, Illa, I, Islam, B, Jellema, K, Kaida, K, Kokubun, N, Kolb, N, van Koningsveld, R, van der Kooi AJ, Kuitwaard, K, Landschoff Lassen, L, Leonhard, Se, Mandarakas, M, Martinez Hernandez, E, Mohammad, Qd, Pulley, M, Rajabally, Ya, Reddel, Sw, van der Ree, T, Roodbol, J, Sachs, Gm, Samijn, Jpa, Santoro, L, Stein, B, Vermeij, Fh, Visser, Lh, Willison, Hj, Wirtz, P, Zivkovich, Sa.
Publikováno v:
Journal of Neurology Neurosurgery and Psychiatry, 91(2), 113-121. BMJ Publishing Group
Journal of neurology, neurosurgery, and psychiatry, 91(2):321496, 113-121. BMJ Publishing Group
Journal of neurology, neurosurgery, and psychiatry, 91(2):321496, 113-121. BMJ Publishing Group
ObjectiveTo compare disease course in patients with Guillain-Barré syndrome (GBS) with a poor prognosis who were treated with one or with two intravenous immunoglobulin (IVIg) courses.MethodsFrom the International GBS Outcome Study, we selected pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::145516eb450725b9efdee64ceadb07ab
https://doi.org/10.1136/jnnp-2019-321496
https://doi.org/10.1136/jnnp-2019-321496
Autor:
Verboon, Christine, van den Berg, Bianca, Cornblath, David R, Venema, Esmee, Gorson, Kenneth C, Lunn, Michael P, Lingsma, Hester, Van den Bergh, Peter, Harbo, Thomas, Bateman, Kathleen, Pereon, Yann, Sindrup, Søren H, Kusunoki, Susumu, Miller, James, Islam, Zhahirul, Hartung, Hans-Peter, Chavada, Govindsinh, Jacobs, Bart C, Hughes, Richard A C, van Doorn, Pieter A
Publikováno v:
Verboon, C, van den Berg, B, Cornblath, D R, Venema, E, Gorson, K C, Lunn, M P, Lingsma, H, Van den Bergh, P, Harbo, T, Bateman, K, Pereon, Y, Sindrup, S H, Kusunoki, S, Miller, J, Islam, Z, Hartung, H-P, Chavada, G, Jacobs, B C, Hughes, R A C, van Doorn, P A & IGOS Consortium 2020, ' Second IVIg course in Guillain-Barré syndrome with poor prognosis : the non-randomised ISID study ', Journal of Neurology, Neurosurgery and Psychiatry, vol. 91, no. 2, pp. 113-121 . https://doi.org/10.1136/jnnp-2019-321496
Verboon, C, van den Berg, B, Cornblath, D R, Venema, E, Gorson, K C, Lunn, M P, Lingsma, H, Van den Bergh, P, Harbo, T, Bateman, K, Pereon, Y, Sindrup, S H, Kusunoki, S, Miller, J, Islam, Z, Hartung, H-P, Chavada, G, Jacobs, B C, Hughes, R A C, van Doorn, P A & IGOS Consortium 2020, ' Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study ', Journal of Neurology, Neurosurgery and Psychiatry, vol. 91, no. 2, pp. 113-121 . https://doi.org/10.1136/jnnp-2019-321496
Verboon, C, van den Berg, B, Cornblath, D R, Venema, E, Gorson, K C, Lunn, M P, Lingsma, H, Van den Bergh, P, Harbo, T, Bateman, K, Pereon, Y, Sindrup, S H, Kusunoki, S, Miller, J, Islam, Z, Hartung, H-P, Chavada, G, Jacobs, B C, Hughes, R A C, van Doorn, P A & IGOS Consortium 2020, ' Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study ', Journal of Neurology, Neurosurgery and Psychiatry, vol. 91, no. 2, pp. 113-121 . https://doi.org/10.1136/jnnp-2019-321496
OBJECTIVE: To compare disease course in patients with Guillain-Barré syndrome (GBS) with a poor prognosis who were treated with one or with two intravenous immunoglobulin (IVIg) courses.METHODS: From the International GBS Outcome Study, we selected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::fa230e32af1c7ff5f1690bef4f9ffc8e
https://portal.findresearcher.sdu.dk/da/publications/cbf30160-af97-4377-a116-681afab1fcce
https://portal.findresearcher.sdu.dk/da/publications/cbf30160-af97-4377-a116-681afab1fcce
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.